A pharmacodynamic model of clinical synergy in multiple myeloma

BACKGROUND: Multiagent therapies, due to their ability to delay or overcome resistance, are a hallmark of treatment in multiple myeloma (MM). The growing number of therapeutic options in MM requires high-throughput combination screening tools to better allocate treatment, and facilitate personalized...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudalagunta, Praneeth, Silva, Maria C., Canevarolo, Rafael R., Alugubelli, Raghunandan Reddy, DeAvila, Gabriel, Tungesvik, Alexandre, Perez, Lia, Gatenby, Robert, Gillies, Robert, Baz, Rachid, Meads, Mark B., Shain, Kenneth H., Silva, Ariosto S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136599/
https://www.ncbi.nlm.nih.gov/pubmed/32268267
http://dx.doi.org/10.1016/j.ebiom.2020.102716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136599/
https://www.ncbi.nlm.nih.gov/pubmed/32268267
http://dx.doi.org/10.1016/j.ebiom.2020.102716

Ejemplares similares